SUPPLEMENTARY MATERIALS FT-MS analysis
To explore the difference between the adhesion of THPDTPI with the resting platelets and AA activated platelets a FT-MS analysis was performed. The resting platelets and AA activated platelets incubated with 5 × 10 −8 M THPDTPI were sufficiently washed with ultrapure water, centrifuged at 500 g for 10 min, received ultrasonication in methanol for 10 min, centrifuged at 500 g for 10 min and the methanol extracts were analyzed with FT-MS. It was found that the methanol extract of AA activated platelets, but not the methanol extract of the resting platelets, gave a negative ion peak at 431.13315, the mass of THPDTPI plus Cl. Therefore only the adhesion of THPDTPI with AA activated platelets is stable enough. This difference could be attributed to P-selectin is stored in α-granules of the resting platelets but occurs on the surface of AA activated platelets. FT-MS spectrograms are provided as Supplementary Figures 1 and 2 .
In vitro anti-platelet aggregation activity assay of THPDTPI
An H-10 cell counter was used to determine the platelet count and a two-channel Chronolog aggregometer was used to evaluate the platelet aggregation. The blood of SD rat was centrifuged at 160 g for 10 min to collect the PRP. The remaining blood was centrifuged for an additional 10 min at 240 g to prepare platelet-poor-plasma (PPP). The final count of the platelets in the PRP was adjusted to 2 × 10 8 platelets/mL with autologous PPP. Into the optical aggregometry testing tuber, 0.5 μL of adjusted PRP and 5 μL of NS or 5 μL of the solution of THPDTPI in NS (final concentration: 5 × 10 
In vivo bleeding time assay
Male ICR mice (20 ± 2 g) were randomly divided into treatment groups (12 per group). The mice were orally treated with THPDTPI (0.01, 0.1 and 1.0 μmol/kg/day) for 10 days, or orally treated with 0.5% carmellose sodium (CMCNa, vehicle, negative control, 0.2 mL/mouse/day) for 10 days. Mice were weighed daily. Twenty-four hours after the last administration, the mice received tail bleeding time assay by following a standard procedure. Briefly, the mouse was placed in a tube holder and its tail was out of the holder. A 2 mm cut was made on the tail. The flowing blood was wiped away with a filter paper every 30 s until it stopped. The yielded bleeding time of the mice treated with 1.0 μmol/kg/day, 0.1 μmol/kg/day and 0.1 μmol/kg/day of THPDTPI as well as 0.2 mL/mouse/day of 0.5% CMCNa were 1622.17 ± 274.43 sec, 1600.17 ± 223.09 sec, 1556.70 ± 226.49 sec and 1636.70 ± 250.19 sec, respectively. THPDTPI did not cause prolonged bleeding time.
Determination of HPLC purity
An Agilent Technologies 1200 Series HPLC (high performance liquid chromate graphy) system (Agilent Technologies, Santa Clara, CA, USA) was used. The sample was separated on a Waters XTerra C18 reversedphase column (2.1 × 150 mm, 5 μm; Waters Limited, Hertfordshire, UK) protected by a guard column of the same material (5 × 10 mm, 5 μm). The column thermostat was maintained at 40°C. To the column, 5 μL of a solution of THPDTPI in ultrapure water was injected for analysis. The mobile phase consisted of water and acetonitrile (5/95). The flow rate was 0.2 mL/min. The column was washed with water and methanol (35/65), and equilibrated to initial conditions for 15 min. Ultraviolet (UV) absorption spectra were recorded online. The UV detector was set to a scanning range of 200-400 nm, and a wavelength of 254 nm was used to monitor THPDTPI. The chromatogram was recorded and gave THPDTPI a retention time of 5.704 min and 98.9% purity.
